Replimune Group (NASDAQ: REPL) shares Q2 2025 financial results and updates

Rhea-AI Filing Summary

Replimune Group, Inc. furnished a current report describing that it issued a news release with its financial results for the second fiscal quarter ended September 30, 2025 and certain corporate updates. The news release is attached as Exhibit 99.1. The company clarifies that this earnings information, including Exhibit 99.1, is being furnished under the securities laws rather than filed, which limits how it is treated for certain liability and incorporation-by-reference purposes.

false 0001737953 0001737953 2025-11-06 2025-11-06 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  November 6, 2025

REPLIMUNE GROUP, INC.

(Exact name of registrant as specified in its charter)

Delaware		001-38596		82-2082553
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification Number)

500 Unicorn Park Drive

Suite 303

Woburn, MA 01801

(Address of principal executive offices, including Zip Code)

Registrant’s telephone number, including area code: (781) 222-9600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.001 per share		REPL		The Nasdaq Stock Market LLC (Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02 Results of Operations and Financial Condition.

On November 6, 2025, Replimune Group, Inc. (the “Company”) issued a news release announcing its financial results for the second fiscal quarter ended September 30, 2025 and certain corporate updates. A copy of the news release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

In accordance with General Instruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibit No.		Description
99.1		News Release dated November 6, 2025
104		Cover page interactive data file (formatted as Inline XBRL)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	REPLIMUNE GROUP, INC.
Date: November 6, 2025	By:	/s/ Sushil Patel
		Sushil Patel
		Chief Executive Officer

FAQ

What did Replimune Group, Inc. (REPL) disclose in this 8-K?

Replimune Group, Inc. reported that it issued a news release announcing its financial results for the second fiscal quarter ended September 30, 2025, along with certain corporate updates, and furnished that release as Exhibit 99.1.

Which period do the latest Replimune (REPL) results cover?

The results discussed in the news release cover Replimune Group, Inc.'s second fiscal quarter ended September 30, 2025.

Where can investors find the detailed Q2 2025 results for Replimune (REPL)?

The detailed second fiscal quarter 2025 financial results and corporate updates are contained in the news release that is attached as Exhibit 99.1 to this report.

Is the Replimune (REPL) earnings release considered filed or furnished?

The company states that the information in Item 2.02, including Exhibit 99.1, is furnished and not deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934.

Does this Replimune (REPL) filing include any major transactions or only results?

The report describes the issuance of a news release with financial results for the second fiscal quarter ended September 30, 2025 and certain corporate updates; any additional detail would be contained in Exhibit 99.1.

Who signed the Replimune (REPL) 8-K related to Q2 2025 results?

The report was signed on behalf of Replimune Group, Inc. by Sushil Patel, the Chief Executive Officer.